Literature DB >> 6202827

Antibodies to hepatitis B surface antigen (HBsAg) elicited by immunization with a synthetic peptide covalently linked to liposomes.

A R Neurath, S B Kent, N Strick.   

Abstract

Peptides synthesized for potential application as antiviral vaccines have been mostly tested in the form of conjugates with carrier proteins. The possible use of several distinct synthetic vaccines in prophylaxis would be facilitated by the availability of fully synthetic immunogens. A synthetic peptide corresponding to residues 135 to 155 ( P135 -155) of hepatitis B surface antigen (HBsAg) failed to elicit in free form anti-peptide antibodies or anti-HBs. However, polymers of P135 -155 (prepared by linking to diaminoalkanes ) and synthetic conjugates prepared by binding P135 -155 to liposomes or polylysine were immunogenic. A poor correlation was observed between anti-peptide and anti-HBs responses elicited by these conjugates. Glutaraldehyde-fixed liposomes appeared to be the carriers of choice for inducing anti-HBs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6202827     DOI: 10.1099/0022-1317-65-5-1009

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  2 in total

1.  Use of reconstituted influenza virus virosomes as an immunopotentiating delivery system for a peptide-based vaccine.

Authors:  F Pöltl-Frank; R Zurbriggen; A Helg; F Stuart; J Robinson; R Glück; G Pluschke
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

Review 2.  The Interplay between Daptomycin and the Immune System.

Authors:  Theodoros Kelesidis
Journal:  Front Immunol       Date:  2014-02-12       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.